Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mahoney

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Interventions|January 11, 2021
Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk PatientsToby Rogers, Christian Shults, Rebecca Torguson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 18, 2021
Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitationD Scott Lim, Robert L Smith, Firas Zahr, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO StudyKendra J Grubb, Hemal Gada, Suneet Mittal, et al.
Lancet (London, England)|October 30, 2025
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trialMayra E Guerrero, David V Daniels, Raj R Makkar, et al.
JACC. Cardiovascular Interventions|June 30, 2025
30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum StudyHemal Gada, Ramzi F Khalil, Stanley J Chetcuti, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2021
Balloon-Expandable Valve Geometry After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Bicuspid Versus Tricuspid Aortic StenosisGiorgio A Medranda, Toby Rogers, Brian J Forrestal, et al.
Circulation. Cardiovascular Interventions|November 21, 2023
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation StudyGilbert H L Tang, Julianne Spencer, Toby Rogers, et al.
JACC. Cardiovascular Interventions|March 5, 2021
Tip-to-Base LAMPOON for Transcatheter Mitral Valve Replacement With a Protected Mitral AnnulusJohn C Lisko, Vasilis C Babaliaros, Jaffar M Khan, et al.
JACC. Cardiovascular Interventions|June 1, 2026
First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective StudyDanny Dvir, Hasan A Jilaihawi, Douglas Fraser, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA RegistryJaffar M Khan, Vasilis C Babaliaros, Adam B Greenbaum, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Interventions|January 11, 2021
Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk PatientsToby Rogers, Christian Shults, Rebecca Torguson, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 18, 2021
Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitationD Scott Lim, Robert L Smith, Firas Zahr, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO StudyKendra J Grubb, Hemal Gada, Suneet Mittal, et al.
Lancet (London, England)|October 30, 2025
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trialMayra E Guerrero, David V Daniels, Raj R Makkar, et al.
JACC. Cardiovascular Interventions|June 30, 2025
30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum StudyHemal Gada, Ramzi F Khalil, Stanley J Chetcuti, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2021
Balloon-Expandable Valve Geometry After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Bicuspid Versus Tricuspid Aortic StenosisGiorgio A Medranda, Toby Rogers, Brian J Forrestal, et al.
Circulation. Cardiovascular Interventions|November 21, 2023
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation StudyGilbert H L Tang, Julianne Spencer, Toby Rogers, et al.
JACC. Cardiovascular Interventions|March 5, 2021
Tip-to-Base LAMPOON for Transcatheter Mitral Valve Replacement With a Protected Mitral AnnulusJohn C Lisko, Vasilis C Babaliaros, Jaffar M Khan, et al.
JACC. Cardiovascular Interventions|June 1, 2026
First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective StudyDanny Dvir, Hasan A Jilaihawi, Douglas Fraser, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA RegistryJaffar M Khan, Vasilis C Babaliaros, Adam B Greenbaum, et al.
Pageof 7